Dosing Regimen Prediction and Confirmation with Rivaroxaban for Thromboprophylaxis in Children after the Fontan Procedure: Insights from the Phase III UNIVERSE Study

This article is protected by copyright. All rights reserved.PMID:34524700 | DOI:10.1002/jcph.1966

Source: The Journal of Clinical Pharmacology - September 15, 2021 Category: Drugs & Pharmacology Authors: Peijuan Zhu Stefan Willmann Wangda Zhou Haitao Yang Alan D Michelson Brian W McCrindle Jennifer S Li Kevin C Harris Liza Miriam Pina Traci Weber Kimberly Nessel Lawrence J Lesko Dagmar Kubitza Peter Zannikos Source Type: research